Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ataxin 1 Antikörper

ATXN1 Reaktivität: Human WB, IHC, ELISA, IF, FACS Wirt: Maus Monoclonal 2F5 unconjugated
Produktnummer ABIN865485
  • Target Alle Ataxin 1 (ATXN1) Antikörper anzeigen
    Ataxin 1 (ATXN1)
    Reaktivität
    • 71
    • 61
    • 33
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 65
    • 44
    • 1
    Maus
    Klonalität
    • 65
    • 45
    Monoklonal
    Konjugat
    • 44
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Ataxin 1 Antikörper ist unkonjugiert
    Applikation
    • 82
    • 44
    • 39
    • 35
    • 29
    • 23
    • 23
    • 22
    • 9
    • 6
    • 5
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of human ATXN1 expressed in E. Coli.
    Klon
    2F5
    Isotyp
    IgG1
    Top Product
    Discover our top product ATXN1 Primärantikörper
  • Applikationshinweise
    WB: 1/500 - 1/2000, IHC: 1/200 - 1/1000, IF: 1/200 - 1/1000, FC: 1/200-1/400 ELISA: Propose dilution 1/10000. Figure 3: Immunofluorescence
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    100g/100l
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
  • Target
    Ataxin 1 (ATXN1)
    Andere Bezeichnung
    ATXN1 (ATXN1 Produkte)
    Hintergrund
    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. Synonyms: ATX1, SCA1, D6S504E, ATXN1
    Molekulargewicht
    87kDa
    Gen-ID
    6310
    Pathways
    Synaptic Membrane
Sie sind hier:
Kundenservice